Voyager Therapeutics logo

Voyager Therapeutics Share Price Today

(NASDAQ: VYGR)

Voyager Therapeutics share price is $3.16 & ₹270.07 as on 18 Apr 2025, 2.30 'hrs' IST

$3.16

0.03

(0.96%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Voyager Therapeutics share price in Dollar and Rupees. Guide to invest in Voyager Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Voyager Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Voyager Therapeutics share price movements

  • Today's Low: $3.09
    Today's High: $3.19

    Day's Volatility :2.98%

  • 52 Weeks Low: $2.75
    52 Weeks High: $9.55

    52 Weeks Volatility :71.2%

Voyager Therapeutics (VYGR) Returns

PeriodVoyager Therapeutics, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-39.46%
-2.8%
0.0%
6 Months
-58.75%
-11.0%
0.0%
1 Year
-57.87%
-1.9%
0.0%
3 Years
-56.41%
-1.5%
-12.9%

Voyager Therapeutics (VYGR) Key Statistics

in dollars & INR

Previous Close
$3.13
Open
$3.11
Today's High
$3.185
Today's Low
$3.09
Market Capitalization
$174.5M
Today's Volume
$338.7K
52 Week High
$9.55
52 Week Low
$2.75
Revenue TTM
$80.0M
EBITDA
$-78.6M
Earnings Per Share (EPS)
$-1.13
Profit Margin
-81.25%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-24.25%

How to invest in Voyager Therapeutics Stock (VYGR) from India?

It is very easy for Indian residents to invest directly in Voyager Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Voyager Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Voyager Therapeutics or VYGR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Voyager Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Voyager Therapeutics shares which would translate to 0.270 fractional shares of Voyager Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Voyager Therapeutics, in just a few clicks!

Returns in Voyager Therapeutics (VYGR) for Indian investors in Rupees

The Voyager Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Voyager Therapeutics investment value today

Current value as on today

₹44,474

Returns

₹55,526

(-55.53%)

Returns from Voyager Therapeutics Stock

₹57,867 (-57.87%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Voyager Therapeutics (VYGR)

-40%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Voyager Therapeutics Stock from India on INDmoney has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Voyager Therapeutics

  • Armistice Capital, LLC

    9.77%

  • BlackRock Inc

    9.70%

  • EcoR1 Capital, LLC

    7.10%

  • Vanguard Group Inc

    5.82%

  • Farallon Capital Management, L.L.C.

    4.66%

  • Dimensional Fund Advisors, Inc.

    2.50%

Analyst Recommendation on Voyager Therapeutics

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Voyager Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Voyager Therapeutics Stock (VYGR)

What analysts predicted

Upside of 409.49%

Target:

$16.10

Current:

$3.16

Insights on Voyager Therapeutics Stock (Ticker Symbol: VYGR)

  • Price Movement

    In the last 6 months, VYGR stock has moved down by -61.2%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 29.57M → 6.27M (in $), with an average decrease of 45.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -9.04M → -34.48M (in $), with an average decrease of 281.3% per quarter
  • VYGR vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 134.4%
  • VYGR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 96.1%
  • Price to Sales

    ForVYGR every $1 of sales, investors are willing to pay $2.3, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Voyager Therapeutics Technicals Summary

Sell

Neutral

Buy

Voyager Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Voyager Therapeutics (VYGR) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Voyager Therapeutics, Inc. logo
-19.33%
-58.75%
-57.87%
-56.41%
-69.64%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Voyager Therapeutics

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. The company's lead product candidate is VY7523, an anti-tau antibody program for the treatment of alzheimer's disease (AD). Its product pipeline includes VY1706, a tau silencing gene therapy in preclinical trial for the treatment of alzheimer's disease; SOD1 silencing gene therapy program for treating amyotrophic lateral sclerosis in preclinical trial; and vectorized anti-amyloid antibody early research program for the treatment of AD in preclinical trial. The company is also developing VY-FXN01 for treating friedreich's ataxia; and GBA1 gene replacement program to treat parkinson's disease. In addition, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Neurocrine Biosciences, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
Organization
Voyager Therapeutics
Employees
172
CEO
Dr. Alfred W. Sandrock Jr., M.D., Ph.D.
Industry
Health Technology

Management People of Voyager Therapeutics

NameTitle
Dr. Alfred W. Sandrock Jr., M.D., Ph.D.
President, CEO & Director
Ms. Robin Swartz
Chief Business Officer & COO
Ms. Jacquelyn Fahey Sandell Esq., J.D.
Chief Legal Officer
Dr. Krystof Bankiewicz M.D., Ph.D.
Founder
Dr. Guangping Gao Ph.D.
Founder & Member of Scientific Advisory Board
Dr. Mark A. Kay M.D., Ph.D.
Founder
Dr. Phillip D. Zamore Ph.D.
Founder & Member of Scientific Advisory Board
Dr. Nathan D. Jorgensen M.B.A., Ph.D.
Chief Financial Officer
Mr. Todd Carter Ph.D.
Chief Scientific Officer
Ms. Michelle Quinn Smith
Chief Human Resources Officer

Important FAQs about investing in VYGR Stock from India :

What is Voyager Therapeutics share price today?

Voyager Therapeutics share price today stands at $3.16, Open: $3.11 ; Previous Close: $3.13 ; High: $3.19 ; Low: $3.09 ; 52 Week High: $9.55 ; 52 Week Low: $2.75.

The stock opens at $3.11, after a previous close of $3.13. The stock reached a daily high of $3.19 and a low of $3.09, with a 52-week high of $9.55 and a 52-week low of $2.75.

Can Indians buy Voyager Therapeutics shares?

Yes, Indians can invest in the Voyager Therapeutics (VYGR) from India.

With INDmoney, you can buy Voyager Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Voyager Therapeutics at zero transaction cost.

How can I buy Voyager Therapeutics shares from India?

It is very easy to buy Voyager Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Voyager Therapeutics (VYGR) be purchased?

Yes, you can buy fractional shares of Voyager Therapeutics with INDmoney app.

What are the documents required to start investing in Voyager Therapeutics stocks?

To start investing in Voyager Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Voyager Therapeutics Stock (VYGR)?

Today’s highest price of Voyager Therapeutics (VYGR) is $3.19.

Today’s lowest price of Voyager Therapeutics (VYGR) is $3.09.

What is today's market capitalisation of Voyager Therapeutics?

Today's market capitalisation of Voyager Therapeutics VYGR is 174.5M

What is the 52 Week High and Low Range of Voyager Therapeutics Stock (VYGR)?

  • 52 Week High

    $9.55

  • 52 Week Low

    $2.75

What are the historical returns of Voyager Therapeutics (VYGR)?

  • 1 Month Returns

    -19.33%

  • 3 Months Returns

    -58.75%

  • 1 Year Returns

    -57.87%

  • 5 Years Returns

    -69.64%

Who is the Chief Executive Officer (CEO) of Voyager Therapeutics ?

Dr. Alfred W. Sandrock Jr., M.D., Ph.D. is the current Chief Executive Officer (CEO) of Voyager Therapeutics.